Factors associated with thrombotic complications after the fontan procedure: A secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the fontan procedure

Journal of the American College of Cardiology

Volumn 61, Issue 3, 2013, Pages 346-353

  McCrindle, Brian W ^a   Manlhiot, Cedric ^a   Cochrane, Andrew ^b   Roberts, Robin ^c   Hughes, Marina ^b   Szechtman, Barbara ^c   Weintraub, Robert ^b   Andrew, Maureen ^a   Monagle, Paul ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

congenital; heart defects; morbidity; pediatrics; surgery

Indexed keywords

ACETYLSALICYLIC ACID; BILIRUBIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CENTRAL VENOUS CATHETER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FONTAN PROCEDURE; HEART VENTRICLE SEPTUM; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY VALVE ATRESIA; PULMONARY VASCULAR DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SURGICAL RISK; THROMBOSIS; THROMBOSIS PREVENTION;

ANTICOAGULANTS; ASPIRIN; CHILD; CHILD, PRESCHOOL; FEMALE; FONTAN PROCEDURE; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; THROMBOSIS; TRICUSPID ATRESIA; WARFARIN;

EID: 84872325501     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.08.1023     Document Type: Article

References (40)

1. S.J. Kim, W.H. Kim, H.G. Lim, J.Y. Lee Outcome of 200 patients after an extracardiac Fontan procedure J Thorac Cardiovasc Surg 136 2008 108 116
2. P. Monagle, T.R. Karl Thromboembolic problems after the Fontan operation Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5 2002 36 47
3. R.G. Seipelt, A. Franke, J.F. Vazquez-Jimenez Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches Ann Thorac Surg 74 2002 556 562
4. G. Balling, M. Vogt, H. Kaemmerer, A. Eicken, H. Meisner, J. Hess Intracardiac thrombus formation after the Fontan operation J Thorac Cardiovasc Surg 119 2000 745 752
5. D.J. Driscoll, K.P. Offord, R.H. Feldt, H.V. Schaff, F.J. Puga, G.K. Danielson Five- to fifteen-year follow-up after Fontan operation Circulation 85 1992 469 496
6. R. Kaulitz, G. Ziemer, R. Rauch Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis) J Thorac Cardiovasc Surg 129 2005 569 575
7. P. Monagle, A. Cochrane, B. McCrindle, L. Benson, W. Williams, M. Andrew Thromboembolic complications after fontan procedures - the role of prophylactic anticoagulation J Thorac Cardiovasc Surg 115 1998 493 498
8. J.S. Tweddell, M. Nersesian, K.A. Mussatto Fontan palliation in the modern era: factors impacting mortality and morbidity Ann Thorac Surg 88 2009 1291 1299
9. D.A. Fyfe, C.H. Kline, R.M. Sade, P.C. Gillette Transesophageal echocardiography detects thrombus formation not identified by transthoracic echocardiography after the Fontan operation J Am Coll Cardiol 18 1991 1733 1737
10. C. Manlhiot, I.B. Menjak, L.R. Brandao Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery Circulation 124 2011 1511 1519
11. C. Manlhiot, L.R. Brandao, J. Kwok Thrombotic complications and thromboprophylaxis across all 3 stages of single ventricle heart palliation J Pediatr 161 2012 513 519
12. P. Khairy, S.M. Fernandes, J.E. Mayer Jr. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery Circulation 117 2008 85 92
13. C. Varma, M.R. Warr, A.L. Hendler, N.S. Paul, G.D. Webb, J. Therrien Prevalence of "silent" pulmonary emboli in adults after the Fontan operation J Am Coll Cardiol 41 2003 2252 2258
14. P. Monagle, E. Chalmers, A. Chan Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 2008 887S 968S
15. P.A. Anderson, R.E. Breitbart, B.W. McCrindle The Fontan patient: inconsistencies in medication therapy across seven pediatric heart network centers Pediatr Cardiol 31 2010 1219 1228
16. N. Madan, B.W. Robinson, M.L. Jacobs Thrombosis in the proximal pulmonary artery stump in a Fontan patient Heart 88 2002 396
17. D.N. Rosenthal, A.H. Friedman, C.S. Kleinman, G.S. Kopf, L.E. Rosenfeld, W.E. Hellenbrand Thromboembolic complications after Fontan operations Circulation 92 1995 287 293
18. A.H. Cromme-Dijkhuis, C.M. Henkens, C.M. Bijleveld, H.L. Hillege, V.J. Bom, J. van der Meer Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations Lancet 336 1990 1087 1090
19. A.H. Cromme-Dijkhuis, J. Hess, K. Hahlen Specific sequelae after Fontan operation at mid- and long-term follow-up Arrhythmia, liver dysfunction, and coagulation disorders J Thorac Cardiovasc Surg 106 1993 1126 1132
20. M. Jahangiri, J. Kreutzer, D. Zurakowski, E. Bacha, R.A. Jonas Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation J Thorac Cardiovasc Surg 120 2000 778 782
21. M. Jahangiri, D. Shore, V. Kakkar, C. Lincoln, E. Shinebourne Coagulation factor abnormalities after the Fontan procedure and its modifications J Thorac Cardiovasc Surg 113 1997 989 992
22. K.C. Odegard, D. Zurakowski, J.A. DiNardo Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion J Thorac Cardiovasc Surg 137 2009 934 941
23. H.B. Ravn, V.E. Hjortdal, E.V. Stenbog Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection Heart 85 2001 61 65
24. P. Monagle, A. Cochrane, R. Roberts A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children J Am Coll Cardiol 58 2011 645 651
25. P.D. Coon, J. Rychik, R.T. Novello, P.S. Ro, J.W. Gaynor, T.L. Spray Thrombus formation after the Fontan operation Ann Thorac Surg 71 2001 1990 1994
26. D.S. Chun, M.S. Schamberger, T. Flaspohler Incidence, outcome, and risk factors for stroke after the Fontan procedure Am J Cardiol 93 2004 117 119
27. R.W. Day, R.S. Boyer, V.F. Tait, H.D. Ruttenberg Factors associated with stroke following the Fontan procedure Pediatr Cardiol 16 1995 270 275
28. C.B. Mahnke, G.J. Boyle, J.E. Janosky, R.D. Siewers, F.A. Pigula Anticoagulation and incidence of late cerebrovascular accidents following the Fontan procedure Pediatr Cardiol 26 2005 56 61
29. E.W. Cheung, G.W. Chay, E.S. Ma, Y.F. Cheung Systemic oxygen saturation and coagulation factor abnormalities before and after the fontan procedure Am J Cardiol 96 2005 1571 1575
30. M. Procelewska, J. Kolcz, K. Januszewska, T. Mroczek, E. Malec Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures - the importance of hemodynamics in the early postoperative period Eur J Cardiothorac Surg 31 2007 866 872
31. H. Tomita, O. Yamada, H. Ohuchi Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations Cardiol Young 11 2001 62 66
32. F. Newall, H. Savoia, J. Campbell, P. Monagle Anticoagulation clinics for children achieve improved warfarin management Thromb Res 114 2004 5 9
33. W. Streif, M. Andrew, V. Marzinotto Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients Blood 94 1999 3007 3014
34. J. Hirsh, J. Dalen, D.R. Anderson Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range Chest 119 2001 8S 21S
35. Y.F. Cheung, G.W. Chay, C.S. Chiu, L.C. Cheng Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure Int J Cardiol 102 2005 509 513
36. S.J. Connolly, M.D. Ezekowitz, S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
37. J.W. Eikelboom, L. Wallentin, S.J. Connolly Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial Circulation 123 2011 2363 2372
38. C.B. Granger, J.H. Alexander, J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
39. L. Wallentin, S. Yusuf, M.D. Ezekowitz Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Lancet 376 2010 975 983
40. V.H. Chan, P. Monagle, P. Massicotte, A.K. Chan Novel paediatric anticoagulants: a review of the current literature Blood Coagul Fibrinolysis 21 2010 144 151